Cargando…

Impact of gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid‐enhanced magnetic resonance imaging on the prognosis of hepatocellular carcinoma after surgery

BACKGROUND AND AIM: Gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid (Gd‐EOB‐DTPA)‐enhanced magnetic resonance imaging (EOB‐MRI) has been recognized as a useful imaging technique to distinguish the biological behavior of hepatocellular carcinoma (HCC). METHODS: We analyzed 217 hepatectomy...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimada, Shingo, Kamiyama, Toshiya, Kakisaka, Tatsuhiko, Orimo, Tatsuya, Nagatsu, Akihisa, Asahi, Yoh, Sakamoto, Yuzuru, Abo, Daisuke, Kamachi, Hirofumi, Taketomi, Akinobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812518/
https://www.ncbi.nlm.nih.gov/pubmed/33490612
http://dx.doi.org/10.1002/jgh3.12444
_version_ 1783637685748891648
author Shimada, Shingo
Kamiyama, Toshiya
Kakisaka, Tatsuhiko
Orimo, Tatsuya
Nagatsu, Akihisa
Asahi, Yoh
Sakamoto, Yuzuru
Abo, Daisuke
Kamachi, Hirofumi
Taketomi, Akinobu
author_facet Shimada, Shingo
Kamiyama, Toshiya
Kakisaka, Tatsuhiko
Orimo, Tatsuya
Nagatsu, Akihisa
Asahi, Yoh
Sakamoto, Yuzuru
Abo, Daisuke
Kamachi, Hirofumi
Taketomi, Akinobu
author_sort Shimada, Shingo
collection PubMed
description BACKGROUND AND AIM: Gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid (Gd‐EOB‐DTPA)‐enhanced magnetic resonance imaging (EOB‐MRI) has been recognized as a useful imaging technique to distinguish the biological behavior of hepatocellular carcinoma (HCC). METHODS: We analyzed 217 hepatectomy recipients with HCCs measuring 10 cm or less. We divided the patients into a decreased intensity (DI) group (n = 189, 87%) and an increased or neutral intensity (INI) group (n = 28, 13%) according to the ratio of tumor intensity to liver intensity during the hepatobiliary phase (HBP). According to the ratio of the maximum tumor diameter (including peritumoral hypointensity) between HBP images and precontrast T1‐weighted images (RHBPP), we divided the patients as follows: The group whose RHBPP was ≥1.036 was the high RHBPP group (n = 60, 28%), and the group whose RHBPP was <1.036 was the low RHBPP group (n = 157, 72%). We investigated the prognoses and clinicopathological characteristics of these patients. RESULTS: DI versus INI was not a prognostic factor for either survival or recurrence; however, a high RHBPP was an independent predictor of unfavorable survival and recurrence in patients. In addition, the INI group showed significantly lower α‐fetoprotein (AFP) levels and higher rates of well‐differentiated HCC and ICGR15 ≥15% than the DI group. The high RHBPP group showed significantly higher rates of vascular invasion and poorly differentiated HCC than the low RHBPP group. CONCLUSIONS: A high RHBPP by EOB‐MRI is a preoperative predictor of vascular invasion and an unfavorable prognostic factor for survival and recurrence. These patients might be considered for highly curative operations such as anatomical liver resection.
format Online
Article
Text
id pubmed-7812518
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wiley Publishing Asia Pty Ltd
record_format MEDLINE/PubMed
spelling pubmed-78125182021-01-22 Impact of gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid‐enhanced magnetic resonance imaging on the prognosis of hepatocellular carcinoma after surgery Shimada, Shingo Kamiyama, Toshiya Kakisaka, Tatsuhiko Orimo, Tatsuya Nagatsu, Akihisa Asahi, Yoh Sakamoto, Yuzuru Abo, Daisuke Kamachi, Hirofumi Taketomi, Akinobu JGH Open Original Articles BACKGROUND AND AIM: Gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid (Gd‐EOB‐DTPA)‐enhanced magnetic resonance imaging (EOB‐MRI) has been recognized as a useful imaging technique to distinguish the biological behavior of hepatocellular carcinoma (HCC). METHODS: We analyzed 217 hepatectomy recipients with HCCs measuring 10 cm or less. We divided the patients into a decreased intensity (DI) group (n = 189, 87%) and an increased or neutral intensity (INI) group (n = 28, 13%) according to the ratio of tumor intensity to liver intensity during the hepatobiliary phase (HBP). According to the ratio of the maximum tumor diameter (including peritumoral hypointensity) between HBP images and precontrast T1‐weighted images (RHBPP), we divided the patients as follows: The group whose RHBPP was ≥1.036 was the high RHBPP group (n = 60, 28%), and the group whose RHBPP was <1.036 was the low RHBPP group (n = 157, 72%). We investigated the prognoses and clinicopathological characteristics of these patients. RESULTS: DI versus INI was not a prognostic factor for either survival or recurrence; however, a high RHBPP was an independent predictor of unfavorable survival and recurrence in patients. In addition, the INI group showed significantly lower α‐fetoprotein (AFP) levels and higher rates of well‐differentiated HCC and ICGR15 ≥15% than the DI group. The high RHBPP group showed significantly higher rates of vascular invasion and poorly differentiated HCC than the low RHBPP group. CONCLUSIONS: A high RHBPP by EOB‐MRI is a preoperative predictor of vascular invasion and an unfavorable prognostic factor for survival and recurrence. These patients might be considered for highly curative operations such as anatomical liver resection. Wiley Publishing Asia Pty Ltd 2020-10-30 /pmc/articles/PMC7812518/ /pubmed/33490612 http://dx.doi.org/10.1002/jgh3.12444 Text en © 2020 The Authors. JGH Open published by Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Shimada, Shingo
Kamiyama, Toshiya
Kakisaka, Tatsuhiko
Orimo, Tatsuya
Nagatsu, Akihisa
Asahi, Yoh
Sakamoto, Yuzuru
Abo, Daisuke
Kamachi, Hirofumi
Taketomi, Akinobu
Impact of gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid‐enhanced magnetic resonance imaging on the prognosis of hepatocellular carcinoma after surgery
title Impact of gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid‐enhanced magnetic resonance imaging on the prognosis of hepatocellular carcinoma after surgery
title_full Impact of gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid‐enhanced magnetic resonance imaging on the prognosis of hepatocellular carcinoma after surgery
title_fullStr Impact of gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid‐enhanced magnetic resonance imaging on the prognosis of hepatocellular carcinoma after surgery
title_full_unstemmed Impact of gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid‐enhanced magnetic resonance imaging on the prognosis of hepatocellular carcinoma after surgery
title_short Impact of gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid‐enhanced magnetic resonance imaging on the prognosis of hepatocellular carcinoma after surgery
title_sort impact of gadolinium‐ethoxybenzyl‐diethylenetriamine pentaacetic acid‐enhanced magnetic resonance imaging on the prognosis of hepatocellular carcinoma after surgery
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812518/
https://www.ncbi.nlm.nih.gov/pubmed/33490612
http://dx.doi.org/10.1002/jgh3.12444
work_keys_str_mv AT shimadashingo impactofgadoliniumethoxybenzyldiethylenetriaminepentaaceticacidenhancedmagneticresonanceimagingontheprognosisofhepatocellularcarcinomaaftersurgery
AT kamiyamatoshiya impactofgadoliniumethoxybenzyldiethylenetriaminepentaaceticacidenhancedmagneticresonanceimagingontheprognosisofhepatocellularcarcinomaaftersurgery
AT kakisakatatsuhiko impactofgadoliniumethoxybenzyldiethylenetriaminepentaaceticacidenhancedmagneticresonanceimagingontheprognosisofhepatocellularcarcinomaaftersurgery
AT orimotatsuya impactofgadoliniumethoxybenzyldiethylenetriaminepentaaceticacidenhancedmagneticresonanceimagingontheprognosisofhepatocellularcarcinomaaftersurgery
AT nagatsuakihisa impactofgadoliniumethoxybenzyldiethylenetriaminepentaaceticacidenhancedmagneticresonanceimagingontheprognosisofhepatocellularcarcinomaaftersurgery
AT asahiyoh impactofgadoliniumethoxybenzyldiethylenetriaminepentaaceticacidenhancedmagneticresonanceimagingontheprognosisofhepatocellularcarcinomaaftersurgery
AT sakamotoyuzuru impactofgadoliniumethoxybenzyldiethylenetriaminepentaaceticacidenhancedmagneticresonanceimagingontheprognosisofhepatocellularcarcinomaaftersurgery
AT abodaisuke impactofgadoliniumethoxybenzyldiethylenetriaminepentaaceticacidenhancedmagneticresonanceimagingontheprognosisofhepatocellularcarcinomaaftersurgery
AT kamachihirofumi impactofgadoliniumethoxybenzyldiethylenetriaminepentaaceticacidenhancedmagneticresonanceimagingontheprognosisofhepatocellularcarcinomaaftersurgery
AT taketomiakinobu impactofgadoliniumethoxybenzyldiethylenetriaminepentaaceticacidenhancedmagneticresonanceimagingontheprognosisofhepatocellularcarcinomaaftersurgery